scispace - formally typeset
A

Alisha V. Ling

Researcher at Boston Children's Hospital

Publications -  5
Citations -  7407

Alisha V. Ling is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: FOXO1 & Insulin. The author has an hindex of 4, co-authored 4 publications receiving 5725 citations. Previous affiliations of Alisha V. Ling include United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Diet rapidly and reproducibly alters the human gut microbiome

TL;DR: Increases in the abundance and activity of Bilophila wadsworthia on the animal-based diet support a link between dietary fat, bile acids and the outgrowth of microorganisms capable of triggering inflammatory bowel disease.
Journal ArticleDOI

Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis

TL;DR: In this article, the authors identify the enzyme flavin-containing monooxygenase 3 (Fmo3) to be a target of insulin and show that FMO3 is suppressed by insulin in vitro, increased in obese/insulin resistant male mice and increased in overweight/inulin resistant humans.
Journal ArticleDOI

Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9

TL;DR: Data indicate that although insulin induces PCSK9 expression, it is not the sole or even dominant regulator ofPCSK9 under all conditions.
Journal ArticleDOI

FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice.

TL;DR: The pervasive role of FoxO1 in mediating the effects of insulin on not only glucose metabolism but also other hormonal signaling pathways and even some aspects of lipid metabolism is revealed.
Journal ArticleDOI

Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids

TL;DR: Insulin, by inhibiting FoxO1 in the liver, reduces 12α-hydroxylated bile acids, cholesterol absorption, and plasma cholesterol levels, which suggest that a personalized approach to lipid lowering in type 1 diabetes may be more effective and highlight the need for further studies specifically in this group of patients.